PTK2 and cancer: Studies using genetically engineered mouse models demonstrate that VASP promotes cell–cell adhesion of endothelial cells and inhibits adhesion and aggregation of platelets.16,17 In vitro experiments reveal that VASP promotes cancer cell migration and proliferation.18 However, it is unknown if VASP regulates the β1-integrin-FAK signaling and GI cancer liver metastasis.